In human melanoma cells, JNK activation was necessary for ΔΨm change and cell apoptosis [91] and treatment with SP600125 prevented both the loss of ΔΨm and the increase in apoptosis by inhibiting JNK activation in different cell types [92,93,94,95]. The gene discussed is MAPK8; the disease is melanoma.